Ensysce Biosciences (ENSC) Return on Assets [ROA] (2018 - 2025)
Ensysce Biosciences' Return on Assets [ROA] was -250.69% in Q3 2025, down 120.53 percentage points from -130.16% a year earlier and down 121.46 percentage points from the prior quarter.
Powered by 
Analysis
Ensysce Biosciences (ENSC) Return on Assets [ROA] (2018 - 2025) Analysis & Trends
For FY2024, Return on Assets [ROA] at Ensysce Biosciences came in at -192.33%, up 54.99 percentage points from FY2023.
- Return on Assets [ROA] shows a five-year change of -191.80 percentage points (FY2019 to FY2024).
- In earlier years, Return on Assets [ROA] was -247.32% in FY2023 (-30.23 pp), -217.09% in FY2022 (+130.53 pp), -347.61% in FY2021 (-347.45 pp) and -0.16% in FY2020 (+0.37 pp).
- The Q3 2025 figure marks the lowest quarterly Return on Assets [ROA] since Q2 2024.
- Compared with a year earlier, Return on Assets [ROA] was higher in six of the last eight quarters, with an average year-over-year change of +111.10 percentage points.
- The best year-over-year quarter for Return on Assets [ROA] over five years was Q4 2024 (a gain of 251.96 percentage points); the worst was Q2 2022 (a drop of 352.70 percentage points).
- Per Business Quant data, ENSC's Return on Assets [ROA] in the three quarters before Q3 2025 was -129.23% (Q2 2025), -133.53% (Q1 2025) and -106.62% (Q4 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | 20.64% |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 8.08% |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | 4.65% |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | 2.45% |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | 10.60% |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 9.10% |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | 9.29% |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | -6.13% |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | 2.14% |
| 10 | Ensysce Biosciences | 1.20 Mn | -10.37 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -250.69% |
| Jun 30, 2025 | -129.23% |
| Mar 31, 2025 | -133.53% |
| Dec 31, 2024 | -106.62% |
| Sep 30, 2024 | -130.16% |
| Jun 30, 2024 | -286.65% |
| Mar 31, 2024 | -296.85% |
| Dec 31, 2023 | -358.59% |
| Sep 30, 2023 | -263.15% |
| Jun 30, 2023 | -384.81% |
| Mar 31, 2023 | -519.36% |
| Dec 31, 2022 | -341.56% |
| Sep 30, 2022 | -354.30% |
| Jun 30, 2022 | -355.41% |
| Mar 31, 2022 | -202.48% |
| Dec 31, 2021 | -222.73% |
| Sep 30, 2021 | -201.44% |
| Jun 30, 2021 | -2.71% |
| Mar 31, 2021 | -0.74% |
| Dec 31, 2020 | 38.93% |
API Access
Ensysce Biosciences Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=ENSC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "ENSC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=ENSC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();